Skip to content

Bioalmanac

Testosterone (TRT)

TRT · Testosterone replacement therapy · Testosterone cypionate · Testosterone enanthate

Approved

Status reviewed 18 Aug 2026

Prohibited in sport

Not a peptide, and the most consequential thing on this site. Approved replacement therapy for diagnosed hypogonadism — a Schedule III controlled substance — and something that will make you infertile while you take it.

Storage

Freeze-dried powder
Supplied as an oil solution, not a powder. Store at room temperature, away from light.
After mixing
Nothing to reconstitute. A multi-dose vial is good until its expiry if the stopper is cleaned before each draw.
Long-term, frozen
Do not refrigerate or freeze. The oil thickens and crystals form.

Dose ranges reported in sources

Descriptions of what sources report, not recommendations.

GoalRangeFrequencySource
Replacement therapy, injectable ester50000–100000 mcgWeekly, or split twice weeklyPublished review

When to stop

  • Chest pain, breathlessness, or leg pain and swelling. Clot symptoms. Seek emergency care.
  • Haematocrit above the range your clinician set. This needs a dose change or a blood donation, not waiting.
  • Breast tenderness or enlargement.
  • Severe mood changes, aggression or worsening depression.
  • Worsening snoring or daytime sleepiness. Sleep apnoea.
  • Reduced urine flow or difficulty passing urine.

Approved by the FDA and EMA for diagnosed male hypogonadism, and a Schedule III controlled substance in the United States. Labelling was updated in 2025 following the TRAVERSE trial. Not approved for age-related decline in testosterone without a confirmed diagnosis.

Arithmetic on values you enter. Not medical advice. Not reviewed by a clinician. · bioalmanac.com/peptides/testosterone

Use your browser’s print dialog and choose “Save as PDF”. This block is hidden when printed.